Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9429367 | Neuroscience Letters | 2005 | 6 Pages |
Abstract
The organic cation transporter-3 (OCT3) can transport monoamines, similar to neuronal monoamine transporters. Due to the lack of selective ligands, however, the functional role of OCT3 is still unknown. Thus, we investigated behavioral effects of antisense against OCT3 (AS) in mice. AS (0.075-0.25 μg/0.25 μl/h, for 7 days) dose-dependently decreased immobility time. Moreover, although neither AS (0.075 μg/0.25 μl/h, for 7 days) or imipramine (4 mg/kg, i.p.) were effective, imipramine (4 mg/kg, i.p.) significantly decreased immobility time in mice treated with AS (0.075 μg/0.25 μl/h, for 7 days). Additionally, AS (0.25 μg/0.25 μl/h, for 7 days) significantly increased locomotor activity induced by methamphetamine (1 mg/kg, s.c.), but did not affect spontaneous locomotor activity. These results suggest that OCT3 might become a novel molecular target to treat depression and other diseases related to monoaminergic neuronal systems.
Keywords
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Kiyoyuki Kitaichi, Masaya Fukuda, Hironao Nakayama, Nagisa Aoyama, Yukiko Ito, Yohei Fujimoto, Kenji Takagi, Kenzo Takagi, Takaaki Hasegawa,